Acquiring Company
Kimberly-Clark
Acquired Company
Kenvue
IrvingSummitManufacturingHealth CareMedicalHealth CareDescription
Kimberly-Clark is set to acquire Kenvue in a cash-and-stock merger, providing Kenvue shareholders with $3.50 in cash and a specified fraction of Kimberly-Clark shares. Shareholder approval has been overwhelmingly positive, and the companies are nearing completion, pending foreign regulatory approval. The deal is expected to close in the fourth quarter, reflecting high market confidence.
Don't miss Kimberly-Clark's next move
Get an email the moment Kimberly-Clark makes an acquisition, hires an exec, or expands, usually minutes after it happens.
One email per event. Unsubscribe anytime.
Related People
M&A Insights
Based on deal dataFrequently asked
Who acquired Kenvue?
Kenvue was acquired by Kimberly-Clark, based in Irving. The deal was reported on September 11, 2026. Kimberly-Clark Corp is an Irving-based consumer products giant with a portfolio of well-known brands such as Huggies, Kleenex, Scott, Kotex, and others. Kimberly-Clark is publicly traded (KMB) and operates in Manufacturing.
When did Kimberly-Clark acquire Kenvue?
Kimberly-Clark's acquisition of Kenvue was reported on September 11, 2026. Kimberly-Clark is set to acquire Kenvue in a cash-and-stock merger, providing Kenvue shareholders with $3.50 in cash and a specified fraction of Kimberly-Clark shares. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Kenvue do?
Kenvue is a consumer health spinoff of Johnson & Johnson, specializing in global corporate affairs and a portfolio of brands including Band-Aid, Listerine, Tylenol, and Neutrogena. It is publicly traded (KVUE), operating in Health Care, and is based in Summit.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.